Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in G1b Treatment-Naïve, HCV-Infected Patients
Clinical trial NCT03496233 · COMPLETED
Trial details
- NCT number
- NCT03496233
- Sponsor
- Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-19
- Primary completion
- 2020-05-20
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.